How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

123 results for

Beard Dermatitis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Beard Dermatitis

Beard Dermatitis Beard Dermatitis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Beard Dermatitis Beard Dermatitis Aka: Beard (...) Dermatitis II. Causes s herpeticum ( ) Sycosis barbae Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Beard Dermatitis." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Examination About FPnotebook.com is a rapid access, point-of-care medical reference for primary care and emergency clinicians. Started in 1995, this collection now contains

2018 FP Notebook

2. Alopecia Areata of the Beard: A Review of the Literature. (PubMed)

Alopecia Areata of the Beard: A Review of the Literature. Alopecia areata (AA) is a T-cell mediated autoimmune disorder in which inflammatory cells attack the hair follicle, resulting in round, well-circumscribed patches of noncicatricial hair loss in normal appearing skin. AA affecting the beard area is well known and is referred to as AA of the beard (BAA) or AA barbae when involvement is limited exclusively to the beard. BAA has been documented in a select number of studies. We review (...) yellow dots, broken hair, and short vellus hairs. BAA may be associated with other autoimmune disorders, including atopic dermatitis, vitiligo, and psoriasis. Many treatment modalities are available for BAA, and selection of a therapy depends on several factors, including disease activity, extent of area affected, duration of disease, and age of the patient. Topical corticosteroids are most commonly used as initial treatment, followed by intralesional steroids. Other therapeutic modalities

2017 American journal of clinical dermatology

3. Beard Dermatitis

Beard Dermatitis Beard Dermatitis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Beard Dermatitis Beard Dermatitis Aka: Beard (...) Dermatitis II. Causes s herpeticum ( ) Sycosis barbae Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Beard Dermatitis." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Examination About FPnotebook.com is a rapid access, point-of-care medical reference for primary care and emergency clinicians. Started in 1995, this collection now contains

2015 FP Notebook

4. Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03359356 Recruitment

2017 Clinical Trials

5. Seborrheic Dermatitis

Seborrheic Dermatitis Seborrheic Dermatitis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Seborrheic Dermatitis Seborrheic (...) Dermatitis Aka: Seborrheic Dermatitis , Seborrhea , Dandruff From Related Chapters II. Epidemiology ral population: 1-3% Immunocompromised: >34% Gender More common in men Age (bimodal) Age 2 to 12 months Adolescent and young adult III. Pathophysiology Altered skin cell functioning Results in skin inflammation with redness, itching and Associated with fungal overgrowth Normal skin colonization with the fungus Malassezia species (Malassezia furfur, Malassezia ovalis) Malassezia invade in Seborrheic

2018 FP Notebook

6. Seborrhoeic dermatitis

. Diagnostic investigations are not usually required, as the rash of seborrhoeic dermatitis is characteristic. However, if there is doubt about the diagnosis, investigations (e.g. skin scrapings to exclude tinea infection) may be indicated. Treatment for seborrhoeic dermatitis treatment is not curative and symptoms often recur after treatment has stopped. Management of seborrhoeic dermatitis of the scalp and beard involves prescribing ketoconazole 2% shampoo (adolescents and adults), selenium sulphide (...) in infants, and when to follow up and refer. : covers what advice to give, how to manage seborrhoeic dermatitis of the scalp and beard areas, and when to follow up or refer. : covers what advice to give, how to manage seborrhoeic dermatitis of the face and body, and when to follow up or refer. : covers the management of people with more severe and widespread seborrhoeic dermatitis. Scenario: Seborrhoeic dermatitis - infants Scenario: Seborrhoeic dermatitis - infants From birth to 12 months. Management

2013 NICE Clinical Knowledge Summaries

7. Seborrheic Dermatitis (Follow-up)

or in beards but may cause inflammation in the intertriginous or facial areas. Systemic low-dose isotretinoin taken by mouth has been reported to benefit severe seborrheic dermatitis. [ ] Metronidazole 1% gel has been evaluated, with inconclusive results for the treatment of seborrheic dermatitis of the face. [ , ] Some suggest using a nonsteroidal cream such as pimecrolimus; patients have reported improvement of up to 80%. [ , ] Bikowski recommends azelaic acid. [ ] Seborrheic blepharitis may respond (...) Seborrheic Dermatitis (Follow-up) Seborrheic Dermatitis Treatment & Management: Medical Care Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTEwODMxMi10cmVhdG1lbnQ= processing > Seborrheic Dermatitis Treatment

2014 eMedicine.com

8. Seborrheic Dermatitis (Treatment)

or in beards but may cause inflammation in the intertriginous or facial areas. Systemic low-dose isotretinoin taken by mouth has been reported to benefit severe seborrheic dermatitis. [ ] Metronidazole 1% gel has been evaluated, with inconclusive results for the treatment of seborrheic dermatitis of the face. [ , ] Some suggest using a nonsteroidal cream such as pimecrolimus; patients have reported improvement of up to 80%. [ , ] Bikowski recommends azelaic acid. [ ] Seborrheic blepharitis may respond (...) Seborrheic Dermatitis (Treatment) Seborrheic Dermatitis Treatment & Management: Medical Care Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTEwODMxMi10cmVhdG1lbnQ= processing > Seborrheic Dermatitis Treatment

2014 eMedicine.com

9. Seborrheic Dermatitis

Seborrheic Dermatitis Seborrheic Dermatitis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Seborrheic Dermatitis Seborrheic (...) Dermatitis Aka: Seborrheic Dermatitis , Seborrhea , Dandruff From Related Chapters II. Epidemiology ral population: 1-3% Immunocompromised: >34% Gender More common in men Age (bimodal) Age 2 to 12 months Adolescent and young adult III. Pathophysiology Altered skin cell functioning Results in skin inflammation with redness, itching and Associated with fungal overgrowth Normal skin colonization with the fungus Malassezia species (Malassezia furfur, Malassezia ovalis) Malassezia invade in Seborrheic

2015 FP Notebook

10. Small-bowel abnormalities in dermatitis herpetiformis. (PubMed)

Small-bowel abnormalities in dermatitis herpetiformis. 5644161 1968 05 23 2018 11 13 0007-1447 1 5591 1968 Mar 02 British medical journal Br Med J Small-bowel abnormalities in dermatitis herpetiformis. 552-5 Marks R R Whittle M W MW Beard R J RJ Robertson W B WB Gold S C SC eng Journal Article England Br Med J 0372673 0007-1447 8002-80-0 Glutens 8W5C518302 Dapsone 935E97BOY8 Folic Acid P6YC3EG204 Vitamin B 12 AIM IM Adolescent Adult Aged Biopsy Bone Marrow Examination Dapsone therapeutic use (...) Dermatitis Herpetiformis blood pathology Diarrhea complications Diet Therapy Female Folic Acid blood Glutens Humans Intestinal Mucosa pathology Jejunum pathology Malabsorption Syndromes complications Male Middle Aged Vitamin B 12 blood 1968 3 2 1968 3 2 0 1 1968 3 2 0 0 ppublish 5644161 PMC1985221 Br J Dermatol. 1967 Oct;79(10):509-18 6061562 Biochem J. 1939 Jun;33(6):920-3 16746992 Br Med J. 1967 Aug 19;3(5563):458-60 20791321 Lancet. 1967 Apr 8;1(7493):739-43 4164117 Postgrad Med J. 1961 Dec;37:717-24

Full Text available with Trip Pro

1968 British medical journal

11. Dermatophyte infections

people, animals, soil, and from fomites. History and exam presence of risk factors history of skin, hair, or nail lesion skin discomfort scaling scalp lesions patchy alopecia erythematous, scaling skin lesions with central clearing erythematous, scaling rash with follicular pustules in beard or moustache erythematous, annular patches on face diffusely dry palmar surface with hyperkeratosis vesicles and scaling of hands erythematous, scaling lesions with raised border on thighs, together with pustules (...) of distal pulses black-dot alopecia milky white nail plate area of leukonychia in the proximal nail plate exposure to infected people, animals, or soil exposure to fomites including hat, combs, hairbrushes, and upholstery wrestling chronic topical or oral corticosteroid use HIV diabetes mellitus and other metabolic disorders occlusive clothing hot, humid weather obesity hyperhidrosis frequenting public bathing areas while barefoot deformities of the feet recurrent trauma to the skin atopic dermatitis

2018 BMJ Best Practice

14. Jeffrey Aronson: When I Use a Word …Wise men pharmacology

. The Shrine of the Three Kings in Cologne Cathedral A mediaeval Armenian depiction by Yovhannes of Bekri (1362) of the three Magi bringing their gifts, as described in the Greek version of Matthew: ἀνοίξαντες τοὺς θησαυροὺς αὐτῶν προσήνεγκαν αὐτῷ δῶρα, χρυσὸν καὶ λίβανον καὶ σμύρναν (opening their treasure chests they offered him their gifts of gold, frankincense, and myrrh). Their legendary names were in the Excerpta et Collectanea: Balthazar (with dark skin and a thick beard), Melchior (with white hair (...) and beard), and Caspar (young, ruddy, and beardless). Melchior’s name is from the Hebrew, malki-or, “my King of light”. Caspar’s name (also found as Gaspar or Jasper) is Persian, from Kansbar, a treasurer. Balthazar’s name is Babylonian, from Baal-tas-assar, “may Baal preserve his life”, related to Belshazzar, whose feast is described in the Book of Daniel, from Bel-shar-uzzur, “May Bel protect the King”. The Babylonian god Bel, mentioned in Isaiah and Jeremiah, was cognate with Baal, a fertility god

2017 The BMJ Blog

15. Evaluation of the Cutera Enlightenâ„¢ Laser With Micro-Lens Array (MLA) Handpiece Attachment

lacerations or abrasions, hidradenitis, rash, infection , or dermatitis of the treatment area prior to treatment (duration of resolution as per the Investigator's discretion). Pregnant and/or breastfeeding, or planning to become pregnant. Significant concurrent illness, such as diabetes mellitus, immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or using immunosuppressive medication. Hypersensitivity to light exposure. Any use of medication that is known to increase (...) vitamin A supplements of ≥ 10,000 units per day) within 12 months of initial treatment or plans on using during the course of the study (note: skin must regain its normal degree of moisture prior to treatment, e.g. lack of noticeable skin flaking and peeling). Excessively tanned or active sun tan in facial area to be treated, or unable/unlikely to refrain from tanning during the study. Excessive facial hair in the area to be treated (beards, sideburns, and/or moustache,) that would interfere

2018 Clinical Trials

16. The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol

condition that would interfere with the diagnosis or assessment of acne vulgaris (e.g., on the face: rosacea, dermatitis, psoriasis, squamous cell carcinoma, eczema, acneform eruptions caused by medications, steroid acne, steroid folliculitis, or bacterial folliculitis). Subjects who have acne conglobata, acne fulminans and secondary acne (e.g.: chloracne and drug induced acne). Excessive facial hair (e.g. beards, sideburns, moustaches, etc.) that would interfere with diagnosis or assessment of acne

2018 Clinical Trials

17. A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris

, perioral dermatitis, lupus, dermatomyositis, psoriasis, eczema, squamous cell carcinoma, acneiform eruptions caused by medications, steroid acne, steroid folliculitis, bacterial folliculitis, or any other facial disease or condition. Excessive facial hair (i.e., heavy beard or mustache), facial tattoos, or facial disfigurement, excessive hair on the neck, upper chest, shoulders and upper back region that would interfere with study assessments. Subjects with a serious and/or chronic medical condition (...) ingredients of these products. The inactive ingredients are sodium lauryl sulphate, stearyl alcohol, cetyl alcohol, gluconolactone, Vitamin E polyethylene glycol succinate, glycerin, carbomer P 971, propylparaben, methylparaben, edetate disodium, butylated hydroxytoluene, medium-chain triglyceride, trolamine, and purified water. Presence of any facial skin disease or condition that would interfere with the study or place the subject at unacceptable risk including sunburn, rosacea, seborrheic dermatitis

2018 Clinical Trials

18. A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

rosacea Phymatous rosacea, Steroid-induced rosacea, severe rosacea including pyoderma faciale) or other concomitant facial dermatoses that are similar to rosacea such as peri-oral dermatitis, demodicidosis, facial keratosis pilaris, seborrheic dermatitis, acute lupus erythematosus, or actinic telangiectasia. Presence of more than two (2) nodulocystic lesions on the face. Presence of less than 3 and more than 20 inflammatory lesions on the face (i.e. papules/pustules). Severe papulopustular rosacea (...) , injected or implanted hormonal methods of contraception or placement of an intrauterine device (IUD) or intrauterine system (IUS) or other forms of hormonal contraception that have comparable efficacy (e.g. vaginal ring or transdermal hormone contraception) Presence of beard or excessive facial hair at Screening which would interfere with the study treatments or study assessments and refusal to remove for duration of study. Carcinoid, Pheochromocytoma or other systemic causes of flushing. Known

2018 Clinical Trials

19. Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

with clinical evaluations such as acne conglobata, acne fulminans, secondary acne, perioral dermatitis, clinically significant rosacea, gram-negative folliculitis, dermatitis, eczema; Any underlying disease(s) or some other dermatological condition of the face that requires the use of interfering topical or systemic therapy or makes evaluations and lesion count inconclusive; Subjects with a facial beard or mustache that could interfere with the study assessments; Subjects with more than two (2) facial

2018 Clinical Trials

20. Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

, secondary acne, perioral dermatitis, clinically significant rosacea, gram-negative folliculitis, dermatitis, eczema; Any underlying disease(s) or some other dermatological condition of the face that requires the use of interfering topical or systemic therapy or makes evaluations and lesion count inconclusive; Subjects with a facial beard or mustache that could interfere with the study assessments; Subjects with more than two (2) facial nodules; Evidence or history of cosmetic-related acne Contacts

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>